Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma.

Levesque, N

Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma. [electronic resource] - Current oncology (Toronto, Ont.) Jan 2008 - 36-41 p. digital

Publication Type: Journal Article

1198-0052

10.3747/co.2008.200 doi